China Pharma Holdings CPHI
NYSE CPHI
$0.67 -0.05 (-6.91%)
As of: Sep 29, 2026 · 3:57 PM EDT

China Pharma Holdings (CPHI) Current Debt (2023)

Updated

China Pharma Holdings (CPHI) reported Current Debt of -$6,011 for Q2 2023.

Analysis

China Pharma Holdings (CPHI) Current Debt (2023) Analysis & Trends

For FY2021, China Pharma Holdings posted Current Debt of $3.83 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 China Pharma Holdings 29.58 Mn 28.46 Mn 83,566.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -6,011.00
Mar 31, 2023 511,125.00
API Access

China Pharma Holdings Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=CPHI&period=max&api_key=YOUR_API_KEY